T

The Neurology Group | Pomona Main Office

Research site

(Unclaimed)

Location

2895 North Town Avenue, Pomona, California, United States of America

Site insights

Top conditions

Top treatments

Topiramate

Atogepant

Ponesimod

KarXT

Erenumab

Pimavanserin

Propranolol

AVP-786

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 10 total trials

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disea...

Enrolling

Alzheimer Disease

Drug: Xanomeline Enteric Capsule

Drug: Xanomeline/Trospium Chloride Capsule

A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy (Empassion)

The main purpose of this study is to compare empasiprubart and IVIg in adult patients with MMN. The study consists of a double-blinded part A (empasi...

Enrolling

MMN

Multifocal Motor Neuropathy (MMN)

Other: Empasiprubart-placebo

Biological: IVIG (Intravenous Immunoglobulin)

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

This goal of this study is to compare three medications used for migraine preventive treatment.This study will compare atogepant, a newer migraine pr...

Enrolling

Migraine

Drug: Topiramate 100 mg

Drug: Propranolol 160 mg

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18...

Enrolling

Acute Treatment of Migraine

Drug: Rimegepant (PF-07899801)

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in chil...

Enrolling

Pediatric Migraine

Drug: Rimegepant/BHV3000

Drug: Matching placebo